← Browse by Condition
Medical Condition

head and neck cancers throat

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05526924 Phase 1
Recruiting

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Enrollment
30 pts
Location
United States
Sponsor
University of Chicago
View Trial →